|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172,600.00 KRW | -1.82% |
|
-1.48% | +0.13% |
| Jul. 14 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| Jul. 07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
Other languages
Search
No results match your criteria
- Stock Market
- Stocks
- A068270 Stock
- News Celltrion, Inc.
- Other languages
Select your edition
All financial news and data tailored to specific country editions
















